Although cocaine addiction and overdose represent a significant health problem in the United States, there is currently no available pharmacologic treatment. This Phase I proposal is aimed at testing a large number of compounds using a high throughput screening (HTS) technique to find selective cocaine antagonists or agonist/ antagonists that may be useful in treating cocaine addiction and overdose. Compounds from in vitro binding and uptake studies will be used in in vivo behavior tests to identify potentially useful compounds.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43DA011615-01S1
Application #
6085793
Study Section
Special Emphasis Panel (ZRG2 (01))
Program Officer
Biswas, Jamie
Project Start
1997-09-30
Project End
2000-03-31
Budget Start
1997-09-30
Budget End
2000-03-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Guilford Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21014